Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer

Inclusion Criteria:

• • >= 30 years

• =< 75 years

• Women with either:

• Genetic test results showing moderately increased breast cancer risk dueto a pathogenic/likely pathogenic variant in ATM, CHEK2, BARD1, RAD51C, orRAD51D (Mutation carrier group) OR

• Calculated lifetime breast cancer risk estimates between 20% and 40%according to the Tyrer-Cuzick V8.0B empiric risk model (Empiric riskgroup)

• Patients provided breast cancer risk assessments by genetic counselors at USCNorris or LA General Hospital beginning in 2021 and at least 12 months ago

• Women recommended to undergo annual breast MRI and/or annual mammogrambeginning at the time of their genetic counseling risk assessment

• English or Spanish speaking patients

Exclusion Criteria:

• • History of breast cancer before genetic counseling at University of SouthernCalifornia (USC)

• Any metastatic cancer diagnosis at time of genetic counseling risk assessment

• Deceased

• Patient underwent a risk reducing mastectomy before their genetic counselingrisk assessment